Patients with acute ischemic stroke frequently test positive for hyperglycemia, which is associated with a poor clinical outcome. This association between poor glycemic control and an unfavorable prognosis is particularly evident in patients with persistent hyperglycemia, patients without a known history of diabetes mellitus, and patients with cortical infarction. To date, however, only one large clinical trial has specifically investigated the effect of glycemic control on stroke outcome. This trial failed to show a clinical benefit, but had several limitations. Despite a lack of clinical evidence supporting the use of glycemic control in the treatment of patients with stroke, international guidelines recommend treating this subset of critically ill patients for hyperglycemia in the hospital setting. This treatment regime is, however, particularly challenging in patients with stroke, and is associated with an increased risk of the patient developing hypoglycemia. Here we review the available evidence linking hyperglycemia to a poor clinical outcome in patients with ischemic stroke. We highlight the pathophysiological mechanisms that might underlie the deleterious effects of hyperglycemia on acute stroke prognosis and systematically review the literature concerning tight glycemic control after stroke. Finally, we provide directions on the use of insulin treatment strategies to control hyperglycemia in this patient group.
Hyperglycemia is frequently observed in patients with ischemic stroke, persists throughout the clinical course of the disorder and is associated with an increased infarct size and a poor clinical outcome
Several pathophysiological mechanisms could account for the detrimental effect of hyperglycemia observed in patients with acute ischemic stroke
No evidence exists that supports the use of glucose lowering therapy for the treatment of hyperglycemia in patients with acute ischemic stroke
Establishing glycemic control in patients with acute ischemic stroke is challenging and carries a substantial risk of the patient developing hypoglycemia
Studies that establish safe methods of improving glycemic control are awaited before randomized controlled trials that assess clinical outcome measures associated with glycemic control can be initiated
Subscribe to Journal
Get full journal access for 1 year
only $17.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Allport, L. et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care 29, 1839–1844 (2006).
Baird, T. A. et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34, 2208–2214 (2003).
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P. & Gerstein, H. C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32, 2426–2432 (2001).
Christensen, H. & Boysen, G. Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke. Eur. J. Neurol. 9, 297–301 (2002).
Dora, B. et al. Prolonged hyperglycemia in the early subacute period after cerebral infarction: effects on short term prognosis. Acta Neurol. Belg. 104, 64–67 (2004).
Gray, C. S., Hildreth, A. J., Alberti, G. K. & O'Connell, J. E. Poststroke hyperglycemia: natural history and immediate management. Stroke 35, 122–126 (2004).
Melamed, E. Reactive hyperglycaemia in patients with acute stroke. J. Neurol. Sci. 29, 267–275 (1976).
Szczudlik, A. et al. Transient hyperglycemia in ischemic stroke patients. J. Neurol. Sci. 189, 105–111 (2001).
Wong, A. A., Schluter, P. J., Henderson, R. D., O'Sullivan, J. D. & Read, S. J. Natural history of blood glucose within the first 48 hours after ischemic stroke. Neurology 70, 1036–1041 (2008).
Berger, L. & Hakim, A. M. The association of hyperglycemia with cerebral edema in stroke. Stroke 17, 865–871 (1986).
Candelise, L., Landi, G., Orazio, E. N. & Boccardi, E. Prognostic significance of hyperglycemia in acute stroke. Arch. Neurol. 42, 661–663 (1985).
Els, T. et al. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc. Dis. 13, 89–94 (2002).
Murros, K., Fogelholm, R., Kettunen, S., Vuorela, A. L. & Valve, J. Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction. J. Neurol. Sci. 111, 59–64 (1992).
Parsons, M. W. et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann. Neurol. 52, 20–28 (2002).
Toni, D. et al. Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion. J. Neurol. Sci. 123, 129–133 (1994).
Furnary, A. P. et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 125, 1007–1021 (2003).
Krinsley, J. S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin. Proc. 79, 992–1000 (2004).
Latorre, J. G. et al. Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke 40, 1644–1652 (2009).
Lazar, H. L. et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109, 1497–1502 (2004).
Malmberg, K. et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J. Am. Coll. Cardiol. 26, 57–65 (1995).
van den Berghe, G. et al. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345, 1359–1367 (2001).
van den Berghe, G. et al. Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 354, 449–461 (2006).
Brunkhorst, F. M. et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N. Engl. J. Med. 358, 125–139 (2008).
Finfer, S. et al. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 360, 1283–1297 (2009).
Gray, C. S. et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 6, 397–406 (2007).
Yong, M. & Kaste, M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II Trial. Stroke 39, 2749–2755 (2008).
Bruno, A., Saha, C., Williams, L. S. & Shankar, R. IV insulin during acute cerebral infarction in diabetic patients. Neurology 62, 1441–1442 (2004).
Bruno, A. et al. Treatment of hyperglycemia in ischemic stroke (THIS). A randomized pilot trial. Stroke 39, 348–349 (2007).
Gray, C. S., Scott, J. F., French, J. M., Alberti, K. G. & O'Connell, J. E. Prevalence and prediction of unrecognized diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 33, 71–77 (2004).
Kernan, W. N. et al. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch. Intern. Med. 165, 227–233 (2005).
Matz, K. et al. Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes Care 29, 792–797 (2006).
Vancheri, F. et al. Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus. QJM 98, 871–878 (2005).
Gauna, C., van den Berghe, G. H. & van der Lely, A. J. Pituitary function during severe and life-threatening illnesses. Pituitary 8, 213–217 (2005).
Vanhorebeek, I., Langouche, L. & van den Berghe, G. Endocrine aspects of acute and prolonged critical illness. Nat. Clin. Pract. Endocrinol. Metab. 2, 20–31 (2006).
van den Berghe, G. Novel insights into the neuroendocrinology of critical illness. Eur. J. Endocrinol. 143, 1–13 (2000).
Feibel, J. H., Hardy, P. M., Campbell, R. G., Goldstein, M. N. & Joynt, R. J. Prognostic value of the stress response following stroke. JAMA 238, 1374–1376 (1977).
Barth, E. et al. Glucose metabolism and catecholamines. Crit. Care Med. 35 (Suppl. 9), S508–S518 (2007).
Seematter, G., Binnert, C., Martin, J. L. & Tappy, L. Relationship between stress, inflammation and metabolism. Curr. Opin. Clin. Nutr. Metab. Care 7, 169–173 (2004).
Gearhart, M. M. & Parbhoo, S. K. Hyperglycemia in the critically ill patient. AACN Clin. Issues 17, 50–55 (2006).
Hunt, D. G. & Ivy, J. L. Epinephrine inhibits insulin-stimulated muscle glucose transport. J. Appl. Physiol. 93, 1638–1643 (2002).
O'Neill, P. A., Davies, I., Fullerton, K. J. & Bennett, D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 22, 842–847 (1991).
Allport, L. E. et al. Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke 35, 1886–1891 (2004).
Meyer, S., Strittmatter, M., Fischer, C., Georg, T. & Schmitz, B. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport 15, 357–361 (2004).
Tarkowski, E. et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26, 1393–1398 (1995).
Vila, N., Castillo, J., Davalos, A. & Chamorro, A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31, 2325–2329 (2000).
Chrousos, G. P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332, 1351–1362 (1995).
del Aguila, L. F., Claffey, K. P. & Kirwan, J. P. TNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am. J. Physiol. 276, E849–E855 (1999).
Rask-Madsen, C. et al. Tumor necrosis factor-α inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 108, 1815–1821 (2003).
Plomgaard, P. et al. Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54, 2939–2945 (2005).
Fuentes, B. et al. The prognostic value of capillary glucose levels in acute stroke: the glycemia in acute stroke (GLIAS) study. Stroke 40, 562–568 (2009).
Stollberger, C., Exner, I., Finsterer, J., Slany, J. & Steger, C. Stroke in diabetic and non-diabetic patients: course and prognostic value of admission serum glucose. Ann. Med. 37, 357–364 (2005).
Stead, L. G. et al. Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocrit. Care 10, 181–186 (2008).
Dungan, K. M., Braithwaite, S. S. & Preiser, J. C. Stress hyperglycaemia. Lancet 373, 1798–1807 (2009).
Egi, M. et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit. Care Med. 36, 2249–2255 (2008).
Umpierrez, G. E. et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J. Clin. Endocrinol. Metab. 87, 978–982 (2002).
Bruno, A. et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 52, 280–284 (1999).
Kruyt, N. D. et al. Hyperglycemia and cognitive outcome after ischemic stroke. J. Neurol. Sci. 270, 141–147 (2008).
Uyttenboogaart, M. et al. Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. Brain 130, 1626–1630 (2007).
Bruno, A. et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59, 669–674 (2002).
Alvarez-Sabin, J. et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator–treated patients. Stroke 34, 1235–1241 (2003).
Alvarez-Sabin, J. et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis. Risk stratification in relation to time to reperfusion. Stroke 35, 2493–2498 (2004).
Leigh, R. et al. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 35, 1903–1907 (2004).
Saposnik, G. et al. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. JAMA 292, 1839–1844 (2004).
Kidwell, C. S., Alger, J. R. & Saver, J. L. Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke 35, 2662–2665 (2004).
Gentile, N. T. et al. Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia. Thromb. Haemost. 98, 1007–1013 (2007).
Rao, A. K., Chouhan, V., Chen, X., Sun, L. & Boden, G. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes 48, 1156–1161 (1999).
Stegenga, M. E. et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 55, 1807–1812 (2006).
Vaidyula, V. R. et al. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 55, 202–208 (2006).
Festa, A. et al. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The insulin resistance atherosclerosis study (IRAS). Arterioscler. Thromb. Vasc. Biol. 19, 562–568 (1999).
Meigs, J. B. et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283, 221–228 (2000).
Pandolfi, A. et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol. 38, 71–76 (2001).
Ribo, M. et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 36, 1705–1709 (2005).
Duckrow, R. B., Beard, D. C. & Brennan, R. W. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 18, 52–58 (1987).
Kawai, N., Keep, R. F., Betz, A. L. & Nagao, S. Hyperglycemia induces progressive changes in the cerebral microvasculature and blood-brain barrier transport during focal cerebral ischemia. Acta Neurochir. Suppl. 71, 219–221 (1998).
Quast, M. J. et al. Perfusion deficit parallels exacerbation of cerebral ischemia/reperfusion injury in hyperglycemic rats. J. Cereb. Blood Flow Metab. 17, 553–559 (1997).
Yip, P. K. et al. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology 41, 899–905 (1991).
Venables, G. S., Miller, S. A., Gibson, G., Hardy, J. A. & Strong, A. J. The effects of hyperglycaemia on changes during reperfusion following focal cerebral ischaemia in the cat. J. Neurol. Neurosurg. Psychiatry 48, 663–669 (1985).
Beckman, J. A., Goldfine, A. B., Gordon, M. B., Garrett, L. A. & Creager, M. A. Inhibition of protein kinase Cβ prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ. Res. 90, 107–111 (2002).
Williams, S. B. et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97, 1695–1701 (1998).
Fleming, I. & Busse, R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R1–R12 (2003).
Vallance, P., Collier, J. & Moncada, S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2, 997–1000 (1989).
Ding, Y., Vaziri, N. D., Coulson, R., Kamanna, V. S. & Roh, D. D. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am. J. Physiol. Endocrinol. Metab. 279, E11–E17 (2000).
Du, X. L. et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108, 1341–1348 (2001).
Tesfamariam, B., Brown, M. L. & Cohen, R. A. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J. Clin. Invest. 87, 1643–1648 (1991).
Inoguchi, T. et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49, 1939–1945 (2000).
Bohlen, H. G. & Nase, G. P. Arteriolar nitric oxide concentration is decreased during hyperglycemia-induced betaII PKC activation. Am. J. Physiol. Heart Circ. Physiol. 280, H621–H627 (2001).
Cosentino, F., Hishikawa, K., Katusic, Z. S. & Luscher, T. F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96, 25–28 (1997).
Jawerbaum, A., Franchi, A. M., Gonzalez, E. T., Novaro, V. & de Gimeno, M. A. Hyperglycemia promotes elevated generation of TXA2 in isolated rat uteri. Prostaglandins 50, 47–56 (1995).
Natarajan, R. et al. Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc. Natl Acad. Sci. USA 90, 4947–4951 (1993).
el-Kashef, H. Hyperglycemia increased the responsiveness of isolated rabbit's pulmonary arterial rings to serotonin. Pharmacology 53, 151–159 (1996).
McCord, J. M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312, 159–163 (1985).
Kamada, H., Yu, F., Nito, C. & Chan, P. H. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood–brain barrier dysfunction. Stroke 38, 1044–1049 (2007).
Wei, J., Huang, N. C. & Quast, M. J. Hydroxyl radical formation in hyperglycemic rats during middle cerebral artery occlusion/reperfusion. Free Radic. Biol. Med. 23, 986–995 (1997).
Suh, S. W. et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann. Neurol. 64, 654–663 (2008).
Bemeur, C. et al. Dehydroascorbic acid normalizes several markers of oxidative stress and inflammation in acute hyperglycemic focal cerebral ischemia in the rat. Neurochem. Int. 46, 399–407 (2005).
Bemeur, C., Ste-Marie, L. & Montgomery, J. Increased oxidative stress during hyperglycemic cerebral ischemia. Neurochem. Int. 50, 890–904 (2007).
Li, S., Zheng, J. & Carmichael, S. T. Increased oxidative protein and DNA damage but decreased stress response in the aged brain following experimental stroke. Neurobiol. Dis. 18, 432–440 (2005).
Muralikrishna, A. R. & Hatcher, J. F. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 40, 376–387 (2006).
Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813–820 (2001).
Esposito, K. et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106, 2067–2072 (2002).
Martini, S. R. & Kent, T. A. Hyperglycemia in acute ischemic stroke: a vascular perspective. J. Cereb. Blood Flow Metab. 27, 435–451 (2007).
Garg, R., Chaudhuri, A., Munschauer, F. & Dandona, P. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 37, 267–273 (2006).
Schurr, A. Lactate: the ultimate cerebral oxidative energy substrate? J. Cereb. Blood Flow Metab. 26, 142–152 (2006).
Siesjo, B. K. Acidosis and ischemic brain damage. Neurochem. Pathol. 9, 31–88 (1988).
Katsura, K., Asplund, B., Ekholm, A. & Siesjo, B. K. Extra- and intracellular pH in the brain during ischaemia, related to tissue lactate content in normo- and hypercapnic rats. Eur. J. Neurosci. 4, 166–176 (1992).
Anderson, R. E., Tan, W. K., Martin, H. S. & Meyer, F. B. Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 30, 160–170 (1999).
[No authors listed] Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke 28, 2109–2118 (1997).
Demchuk, A. M. et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 30, 34–39 (1999).
Tanne, D. et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the multicenter rt-PA stroke survey. Circulation 105, 1679–1685 (2002).
Hawkins, B. T., Lundeen, T. F., Norwood, K. M., Brooks, H. L. & Egleton, R. D. Increased blood–brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50, 202–211 (2007).
Griesdale, D. E. et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180, 821–827 (2009).
Malmberg, K. et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur. Heart J. 26, 650–661 (2005).
Ceremuzynski, L. et al. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc. Drugs Ther. 13, 191–200 (1999).
Diaz, R. et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 98, 2227–2234 (1998).
Mehta, S. R. et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293, 437–446 (2005).
Cheung, N. W., Wong, V. W. & McLean, M. The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29, 765–770 (2006).
van den Berghe, G. et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55, 3151–3159 (2006).
van den Berghe, G. How does blood glucose control with insulin save lives in intensive care? J. Clin. Invest. 114, 1187–1195 (2004).
van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F. & Wouters, P. J. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64, 1348–1353 (2005).
Kruyt, N. D. et al. High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry 79, 1382–1385 (2008).
Kruyt, N. D. et al. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 40, e424–e430 (2009).
Ringleb, P. A. et al. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis. 25, 457–507 (2008).
Adams, H. P. Jr et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115, e478–e534 (2007).
Casaubon, L. K. et al. Variability in physician care practices for glucose treatment in stroke patients. Can. J. Neurol. Sci. 35, 573–582 (2008).
Hirsch, I. B. Sliding scale insulin—time to stop sliding. JAMA 301, 213–214 (2009).
Queale, W. S., Seidler, A. J. & Brancati, F. L. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch. Intern. Med. 157, 545–552 (1997).
Umpierrez, G. E., Palacio, A. & Smiley, D. Sliding scale insulin use: myth or insanity? Am. J. Med. 120, 563–567 (2007).
Hassan, E. Hyperglycemia management in the hospital setting. Am. J. Health Syst. Pharm. 64 (Suppl. 6), S9–S14 (2007).
Inzucchi, S. E. Clinical practice. Management of hyperglycemia in the hospital setting. N. Engl. J. Med. 355, 1903–1911 (2006).
Weng, J. et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 371, 1753–1760 (2008).
Kruyt, N. D. et al. Subjecting acute ischemic stroke patients to continuous tube feeding and an intensive computerized protocol establishes tight glycemic control. Neurocrit. Care doi:10.1007/s12028-009-9230-z.
Morris, A. et al. An electronic protocol for translation of research results to clinical practice: a preliminary report. J. Diabetes Sci. Technol. 2, 802–808 (2008).
Rood, E., Bosman, R. J., van der Spoel, J. I., Taylor, P. & Zandstra, D. F. Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J. Am. Med. Inform. Assoc. 12, 172–180 (2005).
Vogelzang, M. et al. Computer-assisted glucose control in critically ill patients. Intensive Care Med. 34, 1421–1427 (2008).
Vriesendorp, T. M. et al. Efficacy and safety of two 5-day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischemic stroke. J. Neurol. Neurosurg. Psychiatry 80, 1040–1043 (2009).
Hemmen, T. M., Meyer, B. C., McClean, T. L. & Lyden, P. D. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center. J. Stroke Cerebrovasc. Dis. 17, 23–25 (2008).
de Courten-Meyers, G. M., Kleinholz, M., Wagner, K. R. & Myers, R. E. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 14, 227–236 (1994).
Zhu, C. Z. & Auer, R. N. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J. Neurosurg. 101, 664–668 (2004).
Walters, M. R., Weir, C. J. & Lees, K. R. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc. Dis. 22, 116–122 (2006).
Gentile, N. T., Seftchick, M. W., Huynh, T., Kruus, L. K. & Gaughan, J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad. Emerg. Med. 13, 174–180 (2006).
Johnston, K. C., Hall, C. E., Kissela, B. M., Bleck, T. P. & Conaway, M. R. Glucose regulation in acute stroke patients (GRASP) Trial. A randomized pilot trial. Stroke 40, 3804–3809 (2009).
Kreisel, S. H. et al. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc. Dis. 27, 167–175 (2008).
The authors wish to thank the following authors for providing additional data on their studies: N. Gentile, K. Johnston, N. MacDougall, Y. Samson and M. Walters. The research of N. D. K. and G. J. B. is supported by a grant from the Academic Medical Center, University of Amsterdam and the University Medical Center Utrecht, The Netherlands. The research of G. J. B. is also supported by grant 907-00-140 from the Netherlands Organization of Scientific Research (ZonMw).
The authors declare no competing financial interests.
About this article
Cite this article
Kruyt, N., Biessels, G., DeVries, J. et al. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol 6, 145–155 (2010). https://doi.org/10.1038/nrneurol.2009.231
Glycosylated Hemoglobin A1c Predicts Intracerebral Hemorrhage with Acute Ischemic Stroke Post-Mechanical Thrombectomy
Journal of Stroke and Cerebrovascular Diseases (2020)
Índice leucoglucémico como predictor de complicaciones en pacientes con accidente cerebrovascular isquémico
Neurología Argentina (2020)
Effect of hyperglycemia on stroke outcome is not homogeneous to all patients treated with mechanical thrombectomy
Clinical Neurology and Neurosurgery (2020)
Intensive Versus Standard Glucose Control in Patients with Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
World Neurosurgery (2020)
Genome-wide blood DNA methylation analysis in patients with delayed cerebral ischemia after subarachnoid hemorrhage
Scientific Reports (2020)